Northwest & Ethical Investments L.P. increased its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 2.2% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 142,060 shares of the company’s stock after purchasing an additional 3,011 shares during the period. Northwest & Ethical Investments L.P.’s holdings in Procter & Gamble were worth $24,605,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. FMR LLC boosted its stake in Procter & Gamble by 2.7% in the 3rd quarter. FMR LLC now owns 26,556,319 shares of the company’s stock worth $4,599,554,000 after purchasing an additional 689,282 shares during the period. Legal & General Group Plc raised its holdings in shares of Procter & Gamble by 0.6% during the 2nd quarter. Legal & General Group Plc now owns 21,632,054 shares of the company’s stock valued at $3,567,556,000 after purchasing an additional 122,190 shares in the last quarter. Fisher Asset Management LLC raised its holdings in shares of Procter & Gamble by 4.7% during the 3rd quarter. Fisher Asset Management LLC now owns 18,380,610 shares of the company’s stock valued at $3,183,522,000 after purchasing an additional 830,476 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Procter & Gamble by 0.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 16,422,470 shares of the company’s stock valued at $2,844,442,000 after purchasing an additional 105,734 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Procter & Gamble by 3.1% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 14,049,651 shares of the company’s stock valued at $2,433,400,000 after purchasing an additional 426,409 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Trading Up 0.0 %
NYSE PG traded up $0.05 during trading on Thursday, reaching $179.36. 5,522,912 shares of the stock traded hands, compared to its average volume of 6,737,879. The firm has a market cap of $422.40 billion, a price-to-earnings ratio of 30.92, a price-to-earnings-growth ratio of 3.82 and a beta of 0.42. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $180.43. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The stock’s 50-day moving average price is $170.22 and its 200 day moving average price is $168.90.
Procter & Gamble Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 69.48%.
Insider Transactions at Procter & Gamble
In other news, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the sale, the insider now owns 19,341 shares in the company, valued at approximately $3,319,882.65. This trade represents a 3.17 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the sale, the insider now owns 11,595 shares of the company’s stock, valued at approximately $2,002,804.35. This represents a 52.47 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 35,233 shares of company stock valued at $6,024,234 over the last 90 days. 0.18% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
A number of research analysts have recently weighed in on the stock. Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a report on Monday, September 30th. Royal Bank of Canada restated a “sector perform” rating and set a $164.00 price target on shares of Procter & Gamble in a report on Monday, October 21st. DA Davidson upgraded shares of Procter & Gamble from a “neutral” rating to a “buy” rating and raised their price target for the company from $160.00 to $209.00 in a report on Monday. JPMorgan Chase & Co. raised their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research note on Thursday, September 19th. Finally, Dbs Bank lowered shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $180.45.
Get Our Latest Stock Report on Procter & Gamble
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Stories
- Five stocks we like better than Procter & Gamble
- Conference Calls and Individual Investors
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Stock Average Calculator
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Are Dividend Challengers?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.